Blog Details

Acute Myeloid Leukaemia (AML) in Children: Symptoms, Treatment & Outcomes

 

A diagnosis of leukemia in a child is never easy to process. While acute myeloid leukaemia in children (AML) is less common than other childhood leukemias, it is a serious condition that requires prompt and intensive treatment.

The encouraging part? Advances in pediatric leukemia treatment have significantly improved outcomes, and many children respond well when care begins early.

This guide will help you understand AML in a clear, simple, and reassuring way—so you know what to expect and how it can be managed.

What Is Acute Myeloid Leukaemia (AML)?

Acute myeloid leukaemia (AML) is a type of cancer that starts in the bone marrow, where blood cells are produced.

In AML, the body makes abnormal immature cells (called myeloblasts) that don’t function properly. These cells grow rapidly and crowd out healthy blood cells, affecting the body’s ability to fight infections, carry oxygen, and control bleeding.

Unlike some slower blood disorders, AML progresses quickly and needs immediate medical attention. However, it is treatable, especially when diagnosed early.

Causes and Risk Factors

The exact cause of AML is often unknown, but certain factors may increase the risk.

Genetic Conditions

Children with genetic disorders such as Down syndrome have a higher chance of developing AML.

Previous Cancer Treatment

Children who have received chemotherapy or radiation therapy in the past may have a slightly increased risk.

Environmental Exposure

Exposure to high levels of radiation or harmful chemicals is linked to leukemia, though this is rare in children.

Bone Marrow Disorders

Certain pre-existing blood disorders can sometimes develop into AML.

In many cases, however, AML develops without a clear cause—so parents should not blame themselves.

Symptoms of AML in Children

The AML symptoms in children often appear quickly and may resemble common illnesses at first.

Common Symptoms

• Persistent fever or frequent infections
• Extreme tiredness or weakness
• Pale skin due to anaemia
• Easy bruising or bleeding

Other Warning Signs

• Bone or joint pain
• Swollen or bleeding gums
• Loss of appetite and weight loss
• Enlarged liver or spleen

Because these symptoms can overlap with other conditions, it’s important to consult a doctor if they persist or worsen.

Diagnosis Process

Diagnosing AML involves several important steps to confirm the condition and determine its subtype.

Blood Tests

Initial tests may show abnormal levels of white blood cells, red blood cells, and platelets.

Bone Marrow Examination

A bone marrow aspiration or biopsy confirms the diagnosis and identifies leukemia cells.

Genetic and Molecular Testing

These tests help classify the type of AML and guide treatment decisions.

Imaging Tests

Scans may be done to check if the disease has affected other parts of the body.

Accurate diagnosis is crucial because AML treatment depends heavily on the specific subtype.

Treatment Options

Treatment for acute myeloid leukaemia in children is usually intensive but carefully structured.

Chemotherapy

This is the primary treatment and involves strong medications to destroy leukemia cells. It is typically given in cycles.

Targeted Therapy

Some children receive drugs that specifically attack cancer cells based on genetic markers.

Stem Cell (Bone Marrow) Transplant

In certain high-risk or relapsed cases, a transplant may be recommended to replace diseased bone marrow with healthy cells.

Supportive Care

Blood transfusions, antibiotics, and nutritional support help manage side effects and keep the child stable during treatment.

Treatment often requires hospital stays, especially during intensive phases.

Prognosis and Survival Rates

The outlook for AML has improved over time, though it remains more challenging compared to some other childhood leukemias.

Survival Rates

The survival rate for AML in children typically ranges from 60% to 75%, depending on several factors.

What Affects Outcomes

• Age and overall health of the child
• Specific subtype of AML
• Response to initial treatment
• Availability of advanced therapies

While treatment can be demanding, many children achieve remission and go on to recover.

AML vs ALL: Key Differences

Understanding the difference between AML and ALL in children can help clarify why treatment approaches vary.

Type of Cells Affected

AML affects myeloid cells, while acute lymphoblastic leukemia (ALL) affects lymphoid cells.

Speed and Treatment Approach

Both are acute (fast-growing), but AML often requires more intensive, shorter-duration treatment, while ALL treatment is longer but generally less intense per phase.

Survival Rates

ALL typically has higher survival rates, but AML outcomes are improving steadily with newer therapies.

Treatment Duration

AML treatment usually lasts several months, whereas ALL treatment can extend over 2–3 years.

Final Thought

A diagnosis of acute myeloid leukaemia in children can feel overwhelming—but it’s important to remember that treatment options today are more advanced than ever.

With early detection, the right medical care, and strong family support, many children successfully overcome AML and return to healthy, active lives. The journey may be challenging, but there is real hope at every step.

FAQs

1. How is AML different from ALL?

AML affects a different type of blood cell (myeloid cells) and usually requires more intensive treatment over a shorter period compared to ALL.

2. Is AML curable in children?

Yes, many children can achieve remission and be cured, especially with early diagnosis and proper treatment.

3. What is the survival rate of AML?

Survival rates range from 60% to 75%, depending on the child’s condition and response to treatment.

4. What are warning signs of AML?

Common warning signs include fatigue, fever, infections, pale skin, easy bruising, bone pain, and loss of appetite.